Showing results (11-20 of 242) with videos related to
Sort By:
Pageof 25
Diabetes, Obesity & Metabolism|February 28, 2001
Differences in treatment and metabolic abnormalities between normo- and hypertensive patients with type 2 diabetes: the Skaraborg Hypertension and Diabetes ProjectC J Ostgren, U Lindblad, E Bøg-Hansen, et al.European Journal of Clinical Pharmacology|September 1, 2005
Understanding adherence to official guidelines on statin prescribing in primary health care--a multi-level methodological approachH Ohlsson, U Lindblad, T Lithman, et al.BMJ (Clinical Research Ed.)|August 24, 1996
Incidence of myocardial infarction in elderly men being treated with antihypertensive drugs: population based cohort studyJ Merlo, J Ranstam, H Liedholm, et al.European Journal of Clinical Pharmacology|May 25, 2001
Association of outpatient utilisation of non-steroidal anti-inflammatory drugs and hospitalised heart failure in the entire Swedish populationJ Merlo, K Broms, U Lindblad, et al.Diabetes, Obesity & Metabolism|January 5, 2011
Can sulphonylurea addition to lifestyle changes help to delay diabetes development in subjects with impaired fasting glucose? The Nepi ANtidiabetes StudY (NANSY)U Lindblad, G Lindberg, N-O Månsson, et al.Journal of Internal Medicine|February 1, 1993
Stroke morbidity in patients treated for hypertension--The Skaraborg Hypertension ProjectU Lindblad, L Råstam, J RanstamEuropean Heart Journal|March 1, 1993
Acute myocardial infarction in patients treated for hypertension in the Skaraborg Hypertension ProjectU Lindblad, L Råstam, J RanstamDiabetic Medicine : a Journal of the British Diabetic Association|September 1, 1996
Oral antidiabetic drugs: an overviewA MelanderEuropean Journal of Clinical Investigation|October 20, 1998
Pharmacological intervention: the antidiabetic approachA MelanderMetabolism: Clinical and Experimental|February 1, 1987
Clinical pharmacology of sulfonylureasA MelanderPageof 25